ポリメラーゼ連鎖反応（PCR）市場：製品、用途、エンドユーザー、地域別、2026年～2032年

ポリメラーゼ連鎖反応（PCR）市場、2026年～2032年

感染症負担の増加、個別化医療革命、ゲノム研究ブーム＆がん診断、ヘルスケア分野のモニタリングこのように、感染症負担の増加、個別化医療革命、ゲノム研究ブーム＆がん診断、ヘルスケア分野におけるモニタリングは、2024年に109億5,000万米ドルを突破し、2032年までに173億2,000万米ドルの評価に達する市場規模の成長を急増させる。

法医学の進歩は、極小の犯罪現場サンプルからDNAプロファイリングを行うため、発展途上国や小規模産業でますます普及しています。このように、法医学の進歩は新興国で人気を集めており、2026年から2032年にかけてCAGR 6.50%で市場が成長することを可能にしています。

ポリメラーゼ連鎖反応（PCR）市場：定義/概要

ポリメラーゼ連鎖反応（PCR）は、極小のDNAサンプルから数百万のコピーを生成できる画期的な技術と考えられています。例えるなら、砂浜の一粒の砂を拡大するようなものです。PCR法では、その一粒一粒を精査できるだけでなく、何百万もの同一の複製を作り出すことができるため、包括的な分析が可能になります。

PCRのプロセスには、綿密に制御された一連のステップがあります。まず、標的DNAを分離し、熱を加えて二重らせんを一本鎖に分離します。その後、プライマー（標的領域の始まりと終わりに一致するように設計された特定のDNA断片）が導入されます。その後、DNAポリメラーゼとして知られる酵素が使用されます。

迅速診断検査の需要増加とPCR技術の採用拡大はポリメラーゼ連鎖反応（PCR）市場の成長にどのような影響を与えるか？

迅速診断検査に対する需要の増加とPCR技術の採用拡大は、ポリメラーゼ連鎖反応（PCR）市場の成長の支配的な理由です。PCR技術は、その正確性、自動化、精度、リアルタイム定量化、感度の高さにより、ますます採用が進んでいます。qPCRは幅広い入力核酸を提供し、研究アプリケーションにおいて実用的で価値のある技術となっています。腫瘍学・遺伝病研究、幹細胞研究、病原体検出、感染症研究、薬理ゲノミクス、医薬品分析、農業バイオテクノロジー、植物科学研究などの分野で多様な応用が見られます。また、法医学分野でも大いに利用されています。

アルツハイマー病、ターナー症候群、パーキンソン病などの慢性疾患や感染症、遺伝性疾患の有病率の増加。さらに、先天性心疾患の患者数が増加しており、正確な診断のために医療専門家による分子診断ツールの使用が必要となっています。不健康な食生活、肥満、タバコやアルコールの多量摂取、座りっぱなしの生活習慣により、がん罹患率は増加すると予想されます。WHOの欧州地域担当局長によると、コロナウイルス感染患者の死因10件のうち8件は、心血管疾患／高血圧、糖尿病、その他の慢性的な基礎疾患を持つ患者でした。qPCR装置と消耗品の需要は、SARS-CoV-2の大流行が牽引しています。COVID-19の罹患率の増加により、予防的スクリーニングの急増が見込まれ、市場の成長を促進します。

新興国におけるQPCR装置コストの高さはポリメラーゼ連鎖反応（PCR）市場の成長をどのように阻害するか？

QPCR装置のコストが高いことがポリメラーゼ連鎖反応（PCR）市場の成長を妨げています。Bio-Rad LaboratoriesのCFX Connect PCR Detection Systemの価格は約1万7,995米ドルであると報告されています。これに対し、Thermo Fisher Scientificの7900 HT qPCRシステムの価格は20,000～3万米ドルです。より正確な結果と感度で知られるデジタルPCR装置はリアルタイムPCR装置より高い価格設定です。手動のdPCR装置のコストは65,000～7万米ドルと推定されるが、自動化されたdPCR装置の価格は10万米ドル近くになります。

さらに、サンプル調製やPCRプロセス中のコンタミネーションが偽陽性の結果につながることが認識されており、これは様々なアプリケーション、特に診断環境において重大な意味を持つ可能性があります。汚染源は多様であり、環境DNA、サンプル間の交差汚染、以前のPCR反応からのキャリーオーバーなどが含まれます。これらの問題を軽減するためには、強固なプロトコールの実施、十分な訓練を受けた人員の雇用、継続的な品質管理手段の維持が必要であることが理解されています。これらの対策には、専用のPCRワークステーションの使用、機器のUV滅菌、各PCRランに陰性コントロールを含めることなどが含まれます。

目次

第1章 世界のポリメラーゼ連鎖反応（PCR）市場のイントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界のポリメラーゼ連鎖反応（PCR）市場の展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 世界のポリメラーゼ連鎖反応（PCR）市場：製品別

• 概要
• 機器
• 試薬・消耗品

第6章 ポリメラーゼ連鎖反応（pcr）の世界市場：用途別

• 概要
• 臨床診断
• ライフサイエンスクラウドベース

第7章 ポリメラーゼ連鎖反応（PCR）の世界市場：エンドユーザー別

• 概要
• 臨床診断ラボ
• 研究機関
• 製薬会社

第8章 ポリメラーゼ連鎖反応（PCR）の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 世界のポリメラーゼ連鎖反応（PCR）市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Merck KGaA, Agilent Technologies, Inc.
• Danaher Corporation
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Abbott Laboratories
• Takara Bio Inc.
• Becton
• Dickinson and Company

第11章 付録

• 関連調査

Polymerase Chain Reaction PCR Market - 2026-2032

The increase in infectious disease burden, personalized medicine revolution, genomics research boom & cancer diagnostics and monitoring in the healthcare sector. Thus, the growing infectious disease burden, personalized medicine revolution, genomics research boom & cancer diagnostics, and monitoring in the healthcare sector surge the growth of market size surpassing USD 10.95 Billion in 2024 to reach the valuation of USD 17.32 Billion by 2032.

Forensic science advancements are becoming more and more popular in developing countries and small-scale industries due to DNA profiling from minuscule crime scene samples. Thus, forensic science advancements are gaining popularity in emerging countries enabling the market to grow at a CAGR of 6.50% from 2026 to 2032.

Polymerase Chain Reaction PCR Market: Definition/ Overview

The Polymerase Chain Reaction (PCR) is considered a groundbreaking technique by which millions of copies can be generated from a minuscule DNA sample. An analogy can be drawn to magnifying a single grain of sand on a beach. Through PCR, not only can that individual grain be scrutinized, but millions of identical replicas can also be produced, enabling comprehensive analysis.

A series of meticulously controlled steps is involved in the PCR process. Initially, the target DNA is isolated and subjected to heat, causing the double helix to be separated into single strands. Primers, which are specific DNA fragments designed to match the target region's beginning and end, are then introduced. Subsequently, an enzyme known as DNA polymerase is employed.

How do the Increasing Demand for Rapid Diagnostic Tests and Growing Adoption of PCR Technologies have any Implications for the Growth of the Polymerase Chain Reaction PCR Market?

The increase in demand for rapid diagnostic tests and the growing adoption of PCR technologies are the dominant reasons for the growth of the polymerase chain reaction PCR market. PCR techniques are being increasingly adopted due to their accuracy, automation, precision, real-time quantification, and sensitivity. A wide range of input nucleic acids is offered by qPCR, making it a practical and valuable technology in research applications. Diverse applications are found in areas such as oncology & genetic disease research, stem cell research, pathogen detection, research of infectious diseases, pharmacogenomics, pharmaceutical analytics, agricultural biotechnology, and plant sciences research. It is also significantly used in forensic sciences.

The increase in the prevalence of chronic & infectious diseases and genetic disorders, such as Alzheimer's disease, Turner syndrome, & Parkinson's disease. Furthermore, the number of patients with congenital heart disease is increasing, necessitating the use of molecular diagnostic tools by medical professionals for accurate diagnoses. Cancer prevalence is expected to be increased by unhealthy dietary habits, obesity, high tobacco & alcohol consumption, and a sedentary lifestyle. According to WHO Regional Director for Europe, 8 out of 10 deaths in coronavirus-infected patients were suffered by those with cardiovascular diseases/hypertension, diabetes, and other chronic underlying conditions. The demand for qPCR equipment and consumables is being driven by the SARS-CoV-2 pandemic. A surge in preventive screenings is expected to be prompted by the increasing incidence of COVID-19, facilitating market growth.

How Does the High QPCR Device Costs in Emerging Countries Impede the Growth of the Polymerase Chain Reaction PCR Market?

The high QPCR device costs hinder the growth of the polymerase chain reaction PCR market. It is reported that the CFX Connect PCR Detection System by Bio-Rad Laboratories is priced at approximately USD 17,995. In comparison, Thermo Fisher Scientific's 7900 HT qPCR system is found to be priced between USD 20,000 and USD 30,000. Digital PCR instruments, which are known for more accurate results and sensitivity, are priced higher than real-time PCR instruments. The cost of a manual dPCR instrument is estimated to be between USD 65,000 and USD 70,000, while automated dPCR instruments can be priced at nearly USD 100,000.

Furthermore, it has been recognized that contamination during sample preparation or the PCR process can lead to false positive results, which can have significant implications in various applications, particularly in diagnostic settings. The sources of contamination are diverse and can include environmental DNA, cross-contamination between samples, or carryover from previous PCR reactions. It is understood that mitigating these issues requires the implementation of robust protocols, the employment of well-trained personnel, and the maintenance of ongoing quality control measures. These measures may include the use of dedicated PCR workstations, UV sterilization of equipment, and the inclusion of negative controls in each PCR run.

Category-Wise Acumens

How Do the Well-Surface Characteristics, And Material Properties Foster the Growth of the Consumables & Reagents Segment?

The consumable & reagents segment dominates in the polymerase chain reaction market. The well-surface characteristics of PCR consumables are being recognized as a critical factor in the segment's growth. It is understood that the surface properties of the wells can significantly impact the efficiency of DNA amplification. Surfaces that are optimized for DNA binding and release are being developed, which is contributing to improved PCR results. Furthermore, it has been noted that different surface treatments are being applied to enhance the compatibility of consumables with various sample types and PCR chemistries.

Material properties of PCR consumables are also being identified as a key driver of the segment's expansion. It is being reported that manufacturers are focusing on developing materials that offer superior heat conductivity and thermal stability. These properties are essential for ensuring rapid and uniform temperature changes during PCR cycles. Furthermore, materials that minimize evaporation and prevent sample loss are being increasingly adopted, which is leading to more consistent and reliable results.

How Do the Disciplines of Personalized Medicine and Genomics Research in the Healthcare Sector Surge the Growth of the Clinical Diagnostics Segment?

The clinical diagnostic segment dominates the polymerase chain reaction market. The growth of the clinical diagnostics segment is being significantly propelled by the rapidly evolving disciplines of personalized medicine and genomics research in the healthcare sector. It is observed that PCR techniques are being increasingly relied upon for crucial activities such as gene analysis and variation detection within these fields. As advancements are made in personalized medicine and genomics, a corresponding surge in the demand for PCR applications is being witnessed in the life sciences sector. The role of PCR in routine diagnostics is being further solidified by the rising burden of infectious diseases, which is contributing to its increased adoption. While both clinical diagnostics and life sciences applications are expected to make substantial contributions to market growth, it is anticipated that clinical diagnostics may hold a slight advantage in the near term due to its established position in routine testing protocols. However, it is projected that the life sciences segment has the potential to emerge as the dominant application in the long run, driven by its association with cutting-edge research and progress in personalized care approaches.

Country/Region-wise Acumens

How the Well-developed Healthcare System Surges the Growth of the Polymerase Chain Reaction PCR Market in North America?

North America is the dominating region in the polymerase chain reaction (PCR) market. The strong market presence in North America is attributed to well-developed healthcare systems, which are characterized by high levels of research funding and access to advanced technologies. A strong understanding of PCR applications is often observed among the general public and healthcare professionals in North America, which is leading to greater demand for diagnostic tests and research tools. Strict guidelines for diagnostic tests and medical devices are enforced by regulatory bodies in North America. This emphasis on quality ensures accuracy and reliability, thereby driving market growth through the adoption of advanced PCR instruments and assays. As a result of these factors, North America's position as the dominant force in the PCR market is being solidified.

How does the Focus on Innovation Foster the Growth of the Polymerase Chain Reaction PCR Market in Europe?

Europe is the fastest-growing region in the polymerase chain reaction (PCR) market during the forecast period characterized by a mature market landscape where innovation is highly prioritized. A significant number of leading research institutions are housed in Europe, where heavy reliance on PCR for various applications in life sciences is observed. The advancement of PCR technology and the fostering of a dynamic market environment are being fueled by government support for research and development activities. A growing emphasis on personalized medicine is being witnessed across Europe, by which a demand for sophisticated PCR tools used in genetic analysis and tailored healthcare approaches is being created. These factors are collectively contributing to Europe's rapid growth in the PCR market, positioning it as a region where cutting-edge developments and increasing adoption of PCR technologies are being consistently observed.

Competitive Landscape

The Polymerase Chain Reaction PCR Market continues to change and evolve with innovations and also new technologies. There is a continuous promotion of new materials and the improvement of sensors. Cloud-based delivery by companies needs to meet new industry requirements and demands. The market share for polymerase chain reaction PCR is an intense and consistently evolving field where new and old players are still fighting for occupation.

Some of the key players operating in the polymerase chain reaction PCR market include:

Hoffmann-La Roche Ltd.

Thermo Fisher Scientific Inc.

Merck KGaA, Agilent Technologies, Inc.

Danaher Corporation

Bio-Rad Laboratories Inc.

QIAGEN N.V.

Abbott Laboratories

Takara Bio Inc.

Becton

Dickinson and Company

Polymerase Chain Reaction (PCR) Market Latest Developments

In October 2024, Abbott Laboratories announced that they got clearance for their Alinity mPCR System, a real-time PCR platform for clinical laboratories. This user-friendly, automated system aimed to expand PCR technology access for various diagnostic applications.

In May 2024, Thermo Fisher Scientific announced the launch of the Applied Biosystems TaqMan MiniChip PCR System, a miniaturized platform for point-of-care settings. This development addressed the market's growing interest in portable PCR solutions for rapid diagnostics in resource-limited environments.

Polymerase Chain Reaction PCR Market, By Category

• Product:
• Instruments
• Reagents & Consumables
• Application:
• Clinical Diagnostics
• Life Sciences Cloud-based
• End User:
• Clinical Diagnostics Labs
• Research Institutions
• Pharmaceutical Companies
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Instruments
• 5.3 Reagents & Consumables

6 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Clinical Diagnostics
• 6.3 Life Sciences Cloud-based

7 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END-USER

• 7.1 Overview
• 7.2 Clinical Diagnostics Labs
• 7.3 Research Institutions
• 7.4 Pharmaceutical Companies

8 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Hoffmann-La Roche Ltd.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Thermo Fisher Scientific Inc.
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Merck KGaA, Agilent Technologies, Inc.
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Danaher Corporation
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Bio-Rad Laboratories Inc.
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 QIAGEN N.V.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Abbott Laboratories
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Takara Bio Inc.
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Becton
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Dickinson and Company
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Research